Wird geladen...
The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
INTRODUCTION: For patients with diffuse large B‐cell lymphoma (DLBCL), standard‐care is rituximab administered with CHOP or CHOP‐like chemotherapy (R‐CHOP). However, the effectiveness and safety of R‐CHOP among DLBCL patients with human immunodeficiency virus (HIV) infection is less clear, as HIV+ p...
Gespeichert in:
| Veröffentlicht in: | Cancer Med |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541135/ https://ncbi.nlm.nih.gov/pubmed/32794362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3362 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|